Mercury Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Mercury Laboratories Ltd. on BSE

Load latest

14 May 2025

Company Update

Mercury Laboratories Ltd - 538964 - Intimation Of Book Closure

BSE India

The Board has approved the app of Mr. Sanjay Patel, as an Independent director, Re app of Mr. Rajendra R Shah as a MD and cessation of Mr. Bharat Mehta

pdf

Mercury Laboratories Ltd.

14 May 2025

Company Update

Mercury Laboratories Ltd - 538964 - Intimation Of Book Closure

BSE India

The Board has approved the appointment of Mr. Sanjay Patel as an Independent director, re-app of MR. Rajendra R Shah and approved cessation of Mr Bharat Mehta

pdf

Mercury Laboratories Ltd.

14 May 2025

Corp. Action

Mercury Laboratories Ltd - 538964 - Corporate Action-Board approves Dividend

BSE India

The Board has recommends final dividend or Rs. 3.5 per equity shares for the FY 2024-25, subject to approval of members

pdf

Mercury Laboratories Ltd.

14 May 2025

Result

Mercury Laboratories Ltd - 538964 - Results For The Financial Year Ended On March 31, 2025

BSE India

Result for the financial year ended on March 31, 2025 is attached

pdf

Mercury Laboratories Ltd.

14 May 2025

Board Meeting

Mercury Laboratories Ltd - 538964 - Board Meeting Outcome for Outcome Of Board Meeting Held On …

BSE India

Outcome of Board Meeting Held On May 14, 2025 is attached

pdf

Mercury Laboratories Ltd.

14 May 2025

Annual Report

Annual report for Mercury Laboratories Ltd. for FY-2025

None

pdf

Mercury Laboratories Ltd.

08 May 2025, 12:36PM

Company Update

Mercury Laboratories Ltd - 538964 - Revised Board Meeting Intimation For Approval Of Audited Financial Results …

BSE India

In the attached Revised Board Meeting intimation, corrected item no 3 of an appointment of Secretarial Auditor.

pdf

Mercury Laboratories Ltd.

08 May 2025, 10:53AM

Board Meeting

Mercury Laboratories Ltd - 538964 - Board Meeting Intimation for Approval Of Audited Financial Results For …

BSE India

Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/05/2025 ,inter alia, to consider and approve 1. the Audited Financial Results For The Quarter And Financial Year Ended On 31St March, 2025 2. To Recommend Dividend, If Any 3. an appointment of Secretarial Auditor for the Financial Year 2025-26, subject to approval of shareholders 4. An appointment of Internal Auditor for the FY 2025-26 5. an appointment of Cost Auditor for the FY 2025-26. 6. To fix the date, time and venue for the 44th Annual General Meeting and approve the draft notice of the 44th Annual General Meeting of the Company. 7. any other items of Agenda, if any

pdf

Mercury Laboratories Ltd.

29 Apr 2025

Corp. Note

Mercury Laboratories Ltd - 538964 - Format of the Annual Disclosure to be made by an …

BSE India

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Mercury Laboratories Ltd 2 CIN NO. L74239MH1982PLC026341 3 Report filed for FY 2024-2025 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2024-25, 25-26 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* Not Applicable Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2023-24, 24-25 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Krishna ShahDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Ashish Vasavada Designation : -Chief Financial Officer Date: 29/04/2025

pdf

Mercury Laboratories Ltd.

29 Apr 2025

Corp. Note

Mercury Laboratories Ltd - 538964 - Format of the Initial Disclosure to be made by an …

BSE India

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyMercury Laboratories Ltd 2CIN NO.L74239MH1982PLC026341 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 3.44 4Highest Credit Rating during the previous FY BB+stable 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Krishna Shah Designation: Company Secretary and Compliance Officer EmailId: secretarial@mercurylabs.com Name of the Chief Financial Officer: Ashish Vasavada Designation: Chief Financial Officer EmailId: cfo@mercurylabs.com Date: 29/04/2025 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.

pdf

Is Mercury Laboratories Ltd. worth buying?

5 Votes:

Buy 80.0%

Hold 20.0%